Hikma Pharmaceuticals Plc 15 July 2024 London, 15 July 2024 - Hikma Pharmaceuticals PLC (Hikma, Group), will announce its interim financial...
Hikma Pharmaceuticals Plc 01 July 2024 Hikma Pharmaceuticals PLC (the Company) Total Voting Rights and Capital LONDON, 1 July 2024 - In...
Hikma Pharmaceuticals Plc 27 June 2024 Hikma Pharmaceuticals PLC Director Declaration In accordance with Listing Rule 9.6.14, Hikma...
Hikma Pharmaceuticals PLC on Monday bolstered its US and injectables business with the purchase of assets from Denmar ...
Hikma Pharmaceuticals Plc 17 June 2024 Hikma acquires Xellia's differentiated portfolio and enhances Injectables pipeline, manufacturing...
Shares in Hikma Pharmaceuticals PLC rose on Tuesday as analysts at Citi increased the bank's net present value price ...
Hikma Pharmaceuticals Plc 05 June 2024 Hikma Pharmaceuticals PLC Notification and public disclosure of transactions by persons discharging...
Hikma Pharmaceuticals Plc 09 May 2024 Hikma Pharmaceuticals PLC (the "Company") LONDON, 9 May 2024: Hikma Pharmaceuticals PLC (LSE: HIK...
Hikma Pharmaceuticals Plc 25 April 2024 Hikma Pharmaceuticals PLC Results of 2024 Annual General Meeting LONDON, 25 April 2024 Hikma...
Hikma Pharmaceuticals PLC on Thursday reported an encouraging start to the year supported by all three business segme ...
Hikma Pharmaceuticals Plc 25 April 2024 Hikma has strong start to 2024, with continued momentum across all businesses. Full year guidance...
Hikma Pharmaceuticals Plc 17 April 2024 Hikma Pharmaceuticals PLC - Discretionary Share Award LONDON, 17 April 2024: Hikma Pharmaceuticals...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.